News

In his new role, Mr Alsobrook oversees Exagen’s day-to-day operations, company alliances and genomic marker discovery and development programs. Mr Alsobrook reports to Waneta Tuttle, founder and interim

In his new position, Mr Diaz will oversee sales, field communications and training, regional field development, events, recognition and incentive programs. Most recently, Mr Diaz served as president

The small business innovation research (SBIR) grant will enable Sequella to perform investigational new drug-directed preclinical in vitro and in vivo potency, pharmacology, and toxicity studies of SQ609,

According to the company, the i60RL Intelligent Surgical Instrument is the world’s first reverse pivot linear cutter, designed to improve medical outcomes by providing surgeons with greater access

The proceeds will support the launch of the company’s Menaflex collagen meniscus implant device in the US, which recently received the FDA clearance. In the recent closing, ReGen

Edward Hu, COO, will serve as acting CFO until a replacement is found. Mr Tsang joined WuXi PharmaTech in 2006 as CFO. The board has formed a search

According to the company, the data at 21 months of median follow up confirms a statistically- significant six-month increase in median survival (17.1 months in the experimental arm

The HepaMate technology has previously been tested in clinical Phase I and pivotal Phase II/III studies involving more than 200 patients. According to the company, a retrospective statistical

Most recently, Mr Falvey served as CFO for Aspect Medical Systems, a provider of brain monitoring technologies. Prior to Aspect, Mr Falvey was vice president of finance at